Synthesis and antiproliferative effects of 5,6-disubstituted Pyridazin-3(2H)-ones designed as conformationally constrained combretastatin A-4 Analogues.

Novel 5,6-disubstituted pyridazin-3(2H)-one derivatives were designed and synthesized as combretastatin A-4 analogues. Our objective was to overcome the spontaneous cis to trans isomerization of the compound. We therefore replaced the cis-double bond with a pyridazine ring. The antiproliferative activity of the novel analogues was evaluated against four human cancer cell lines (HL-60, MDAMB- 435, SF-295 and HCT-8). We found that the analogues had little activity either against selected cell lines or against purified tubulin. Molecular modeling studies may account for their inactivity.

[1]  J. Hartley,et al.  Acetyl analogs of combretastatin A-4: synthesis and biological studies. , 2011, Bioorganic & medicinal chemistry.

[2]  A. Couture,et al.  Synthesis and cytotoxic evaluation of cis-locked and constrained analogues of combretastatin and combretastatin A4 , 2010 .

[3]  A. Brancale,et al.  Synthesis and antitumor activity of 1,5-disubstituted 1,2,4-triazoles as cis-restricted combretastatin analogues. , 2010, Journal of medicinal chemistry.

[4]  H. Kaur,et al.  Advances in Synthetic Approaches for the Preparation of Combretastatin-Based Anti-Cancer Agents , 2009 .

[5]  R. Rossi,et al.  Regioselective Synthesis of 4,5‐Diaryl‐1‐methyl‐1H‐imidazoles Including Highly Cytotoxic Derivatives by Pd‐Catalyzed Direct C‐5 Arylation of 1‐Methyl‐1H‐imidazole with Aryl Bromides , 2008 .

[6]  J. Bourguignon,et al.  Synthesis of Regiospecifically Polysubstituted Pyridazinones. , 2008 .

[7]  D. Villemin,et al.  Isonitriles as Efficient Ligands in Suzuki—Miyaura Reaction. , 2007 .

[8]  C. Wermuth,et al.  Palladium-Catalyzed Cross-Coupling Reactions on Pyridazine Moieties , 2007 .

[9]  Sonia Arora,et al.  Highly potent triazole-based tubulin polymerization inhibitors. , 2007, Journal of medicinal chemistry.

[10]  G. Tron,et al.  Synthesis and cytotoxic evaluation of combretafurazans. , 2005, Journal of medicinal chemistry.

[11]  G. Giannini,et al.  Heterocyclic and phenyl double-bond-locked combretastatin analogues possessing potent apoptosis-inducing activity in HL60 and in MDR cell lines. , 2005, Journal of medicinal chemistry.

[12]  H. Hsieh,et al.  Concise synthesis and structure-activity relationships of combretastatin A-4 analogues, 1-aroylindoles and 3-aroylindoles, as novel classes of potent antitubulin agents. , 2004, Journal of medicinal chemistry.

[13]  Patrick A. Curmi,et al.  Insight into tubulin regulation from a complex with colchicine and a stathmin-like domain , 2004, Nature.

[14]  V. Villalobos,et al.  Synthesis and biological evaluation of aryl azide derivatives of combretastatin A-4 as molecular probes for tubulin. , 2000, Bioorganic & medicinal chemistry.

[15]  B Vojnovic,et al.  Combretastatin A-4 phosphate as a tumor vascular-targeting agent: early effects in tumors and normal tissues. , 1999, Cancer research.

[16]  E. Hamel.  Evaluation of antimitotic agents by quantitative comparisons of their effects on the polymerization of purified tubulin , 2007, Cell Biochemistry and Biophysics.